Drug-related problems in elderly patients with AECOPD and pharmaceutical intervention practice: a prospective study
Frontiers in Pharmacology · 19.06.2025 · 16
DOI: 10.3389/fphar.2025.1596795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.06.2025. Verfasst von Zengqing Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gaochun Hospital Affiliated to Jiangsu University, Nanjing, Jiangsu, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Elderly patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) face an elevated risk of drug-related problems (DRPs) owing to age-related decline in physiological reserve and multiple comorbidities. This study aims to systematically identify and categorize the DRPs of elderly patients with AECOPD, analyze their causes and risk factors, and evaluate the impact of pharmaceutical interventions on resolving DRPs.
Methods
Elderly patients hospitalized with AECOPD at Gaochun Hospital Affiliated to Jiangsu University were enrolled in this prospective study from 1 January 2023 to 31 December 2024. Clinical pharmacists classified and documented DRPs using the Pharmaceutical Care Network Europe (PCNE) V9.1 Classification System, followed by targeted pharmaceutical interventions based on causes of DRPs.
Results
A total of 544 AECOPD patients were included in the study. Among them, 393 DRPs were identified in 300 patients, resulting in an occurrence rate of 55.15%. “P2 Treatment safety” was the major DRPs ( n = 177, 45.04%). Univariate and multivariate analysis showed that the number of drugs >15 (OR: 136.648, 95% CI: 38.693–482.583) and the number of comorbidities >2 (OR: 161.092, 95% CI: 43.880–591.402) were the risk factors for DRPs (P < 0.001). 472 causes were analyzed by clinical pharmacists. “C9.1 No or inappropriate outcome monitoring (including TDM)” was the most common cause of DRPs ( n = 163, 34.53%). Clinical pharmacists proposed 435 interventions to address DRPs, of which 398 (91.49%) interventions were accepted. In the end, 294 (74.81%) DRPs were totally solved, and 18 (4.58%) DRPs were partially solved.
Conclusion
The incidence of DRPs is high in elderly hospitalized patients with AECOPD in China. The number of comorbidities and prescription drugs are important predictors for DRPs. The active involvement of clinical pharmacists in the management of AECOPD patients can enhance both the safe and effective use of medications among elderly patients, as well as the overall quality of pharmaceutical care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Gaochun Hospital Affiliated to Jiangsu University, Nanjing, Jiangsu, China.
- Department of Respiratory and Critical Care Medicine, Gaochun Hospital Affiliated to Jiangsu University, Nanjing, Jiangsu, China.
Zitieren
APA
Ma, Z., Shi, H., Hong, G., Wu, L., & Lin, Y. (2025). Drug-related problems in elderly patients with AECOPD and pharmaceutical intervention practice: a prospective study. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1596795
Vancouver
Ma Z, Shi H, Hong G, Wu L, Lin Y. Drug-related problems in elderly patients with AECOPD and pharmaceutical intervention practice: a prospective study. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1596795
BibTeX
@article{Ma2025,
author = {Ma, Zengqing and Shi, Hongjun and Hong, Guojun and Wu, Lianping and Lin, Yu},
title = {Drug-related problems in elderly patients with AECOPD and pharmaceutical intervention practice: a prospective study},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1596795}
}
EUVIMED